Boston Business Journal (blog) “Our pre-clinical data clearly show that RNAi therapeutics targeting ALAS-1 can achieve potent, rapid, and durable suppression of the toxic heme biosynthesis intermediates that cause the symptoms and disease pathology of AIP. As such, these findings ... and more »
The Garden City Telegram DuVall swept his two specialties — clocking his fastest electronic time of the season, 14.07 in the 110-meter high hurdles, and then broke Anthony Brown's record in the 300-meter intermediates with a blistering 38.14, breaking Brown's 2006 mark of 38.41. and more »
News-Medical.net "Our pre-clinical data clearly show that RNAi therapeutics targeting ALAS-1 can achieve potent, rapid, and durable suppression of the toxic heme biosynthesis intermediates that cause the symptoms and disease pathology of AIP. As such, these findings ... and more »
